McKesson Corporation ( MCK ) UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM EST Company Participants Britt Vitalone - Executive VP & CFO Conference Call Participants Kevin Caliendo -
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
Revenue: Increased 10% year over year to $103 billion.Adjusted Earnings per Diluted Share: Increased 39% to $9.86.Guidance on Adjusted Earnings per Diluted Sha
McKesson Corporation ( MCK ) Q2 2026 Earnings Call November 5, 2025 4:30 PM EST Company Participants Jeni Dominguez - Head of Investor Relations Brian Tyler - CEO & Director Britt Vitalone - Executive
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compa

McKesson (MCK) Surpasses Q2 Earnings Estimates

06:26pm, Wednesday, 05'th Nov 2025
McKesson (MCK) came out with quarterly earnings of $9.86 per share, beating the Zacks Consensus Estimate of $8.92 per share. This compares to earnings of $7.07 per share a year ago.
Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve
McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.

McKesson (MCK) to Release Earnings on Wednesday

03:02am, Tuesday, 04'th Nov 2025
McKesson (NYSE: MCK - Get Free Report) is expected to post its Q2 2026 results after the market closes on Wednesday, November 5th. Analysts expect McKesson to post earnings of $8.84 per share and reve
UnitedHealth Group, Cardinal Health, Johnson and Johnson, Intuitive Surgical, Hims and Hers Health, McKesson, and Baxter International are the seven Healthcare stocks to watch today, according to Mark
Beyond analysts' top-and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter

McKesson Corporation Declares Quarterly Dividend

08:00am, Thursday, 30'th Oct 2025
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on J
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE